Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2007
05/18/2007WO2007011647A3 Inhibitors of mitotic kinesin ksp
05/18/2007WO2007007160A3 Anti-madcam antibodies to treat fever
05/18/2007WO2006110577A3 Use of fril proteins for reducing the production of pro-inflammatory cytokines
05/18/2007WO2006106438A3 Modulators of ppar activity
05/18/2007WO2006103118A3 Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases
05/18/2007WO2006035244A8 Ecteinascidin compounds as anti -inflammatory agents
05/18/2007CA2628260A1 2-phenyl-2h-pyraz0le derivatives as p2x7 receptor antagonists and uses thereof
05/18/2007CA2627263A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor
05/18/2007CA2626443A1 Oxazole and thiazole ppar modulators
05/17/2007US20070112205 Cyanopyrrolidine derivatives
05/17/2007US20070112059 Cyanopyrrolidine derivatives
05/17/2007US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors
05/17/2007US20070112029 Piperidine compound and process for preparing the same
05/17/2007US20070112025 Use of kynurenine-3-hydroxylase inhibitors for the preparation of medicaments for the treatment of l-dopa induced movement disorders, dyskinesias, drug addiction, pain and cataract
05/17/2007US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
05/17/2007US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
05/17/2007US20070111934 Procaspase 1 activation inhibitor
05/17/2007US20070111931 Compositions and methods for promoting wound healing and tissue repair
05/17/2007US20070111266 Antibodies to murine zcytor17 ligand
05/17/2007US20070110835 Method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity
05/17/2007US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
05/16/2007EP1785134A2 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
05/16/2007EP1785132A1 Constitutional function-improving agents
05/16/2007EP1785131A1 External preparation of s/o type
05/16/2007EP1784397A1 5-(1,1'-biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use
05/16/2007EP1784391A1 Phenanthridine carbonyl phenols as cytokine expression modulators
05/16/2007EP1784223A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
05/16/2007EP1784177A2 Novel formulation for l-tryptophane comprising carbidopa/benserazide
05/16/2007EP1306373B1 3,4-dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient
05/16/2007EP1305285B1 N-substituted indoles useful in the treatment of diabetes
05/16/2007EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
05/16/2007EP0989853B1 Self-regulated apoptosis of inflammatory cells by gene therapy
05/16/2007CN1964956A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
05/16/2007CN1964737A Methods of using IL-1 antagonists to treat autoinflammatory disease
05/16/2007CN1964703A Immediate release pharmaceutical tablets with height greater than width
05/16/2007CN1962656A Indomethacin 5-fluorouracil methyl ester pharmaceutical compound and its formulation and preparation method
05/16/2007CN1962650A Process for preparing high-purity dehydrated andrographolide
05/16/2007CN1962641A Metalloproteinase inhibitors
05/16/2007CN1962639A Lappaconitine hydrochoric acid, its production method and its uses in preparing analgetic
05/16/2007CN1962614A Felbinac acetaminopher ester and its preparation method
05/16/2007CN1962596A Ketone compounds and compositions for cholesterol management and related uses
05/16/2007CN1961953A Tablet with chain fern and black snake for treating bone disease
05/16/2007CN1961948A Tincture for treating pain and arthralgia due to wind cold-dampness
05/16/2007CN1961945A Herbal liquor impregnated agent cover
05/16/2007CN1961943A Pharmaceutical composition for treating cold, its preparation method and quality control method thereof
05/16/2007CN1961937A Ointment for moving blood, resolving stasis, reducing swelling and easing pain and preparation process thereof
05/16/2007CN1961934A Method for preparing Chinese medicinal wine for treating humerus lateral epicondylitis
05/16/2007CN1961928A Blood circulation-activating stasis-removing medicament for treating blood stasis syndrome and preparation process thereof
05/16/2007CN1961912A Chinese medicinal composition containing pain-easing bleeding-stopping functions
05/16/2007CN1961887A Sustained releasing formulation of compound glucosamine, preparation process and application thereof
05/16/2007CN1961866A Nano-emulsion drug of triperygium wilfordii polycoride and preparation method thereof
05/16/2007CN1315867C 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
05/16/2007CN1315848C Novel compound
05/16/2007CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
05/16/2007CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain
05/16/2007CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
05/16/2007CN1315834C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
05/16/2007CN1315833C Azaindole kinase inhibitors
05/16/2007CN1315822C Quinoline derivatives having VEGF inhibiting activity
05/16/2007CN1315820C Thiophene carboxamides as inhibitors of the enzyme IKK-2
05/16/2007CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
05/16/2007CN1315803C Aminopyridyl-substituted phenyl acetamides as protease inhibitors
05/16/2007CN1315524C Externally applied ointment for treating pains of neck, shoulder, waist and limbs and its preparation process
05/16/2007CN1315521C Coating film preparation for dispelling swelling and relieving pain and its preparation method
05/16/2007CN1315516C Medicine for treating rheumatic disease
05/16/2007CN1315508C Borneol toad pain-stopping adhesive plaster and its preparation method
05/16/2007CN1315498C Effervescence tablet for quickly allaying infantile fever and its preparation method
05/16/2007CN1315479C Use of oleuropein in preparation of drug for inhibiting angiogenesis
05/16/2007CN1315464C Wild aconite drip pill for treating cancer pain and its preparation method
05/15/2007USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold
05/15/2007US7217732 Cannabinoid receptor agonists
05/15/2007US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists
05/15/2007US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses
05/15/2007US7217694 Inhibitors of IAPP fibril formation and uses thereof
05/15/2007US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
05/15/2007US7217422 Compositions and methods for enhancing corticosteroid delivery
05/15/2007US7217416 Use of gamma globulin for the topical treatment of lesions of dermatitis
05/15/2007US7217414 Methods of preventing peritonitis by administering lactic acid bacterium
05/15/2007CA2392973C Benzoimidazole derivatives useful as antiproliferative agents
05/15/2007CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
05/15/2007CA2266811C Method and composition for wound treatment
05/15/2007CA2176948C Chaperonin 10
05/15/2007CA2011633C Intercellular adhesion molecule - 2 and its binding ligands
05/10/2007WO2007053499A2 Compounds useful as antagonists of ccr2
05/10/2007WO2007053495A2 Compounds useful as antagonists of ccr2
05/10/2007WO2007053346A1 Pyrazole-isoquinoline urea derivatives as p38 kinase inhibitors
05/10/2007WO2007052999A1 Pharmaceutical compositions combining analgesics and anticonvulsant agents for the treatment of chronic and acute pain
05/10/2007WO2007052793A1 Patch
05/10/2007WO2007052134A1 (2s)-2-aminomethyl-5-ethyl heptanoic acid its pharmaceutical use
05/10/2007WO2007052013A1 A combination of cannabinoids for the treatment of peripheral neurophatic pain
05/10/2007WO2007052000A1 Pyrazoles useful in the treatment of inflammation
05/10/2007WO2007051982A1 Triazole compounds as lipoxygenase inhibitors
05/10/2007WO2007051981A1 Pyrazoles useful in the treatment of inflammation
05/10/2007WO2007051358A1 HYDROXYPROPYL-SULFOBUTYL-β-CYCLODEXTRIN, THE PREPARATION METHOD,THE ANALYTICAL METHOD AND THE PHARMACUTICAL APPLICATION THEREOF
05/10/2007WO2007051317A1 Compositions and methods for treating atherosclerosis
05/10/2007WO2007002701A3 Anti-inflammatory aryl nitrile compounds
05/10/2007WO2006138373A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
05/10/2007WO2006124477A3 Combination therapy with inhibitors of hmgb and caspase for the treatment of inflammatory diseases